期刊文献+

鳞状上皮细胞癌抗原检测在宫颈鳞癌中的临床意义 被引量:6

下载PDF
导出
摘要 目的探讨鳞状上皮细胞癌抗原(SCCAg)检测在宫颈鳞癌中的临床意义。方法用全自动快速荧光酶标分析仪系统检测48例宫颈鳞癌患者。结果SCCAg对于宫颈鳞癌的诊断灵敏性为58.33%,特异性为95.71%。SCCAg阳性率随临床分期进展而增高,相互之间有显著性差异(P<0.01)。SCCAg在宫颈鳞癌的表达与临床分期、淋巴结转移有关(P<0.01和P<0.05)。术后宫颈鳞癌患者SCCAg水平较术前有显著下降(P<0.01)。随访结果表明SCCAg升高与肿瘤复发、转移有关。结论SCCAg是宫颈鳞癌较特异的肿瘤标志物,在宫颈鳞癌的辅助诊断、治疗效果及预后的判断有较大的价值。
作者 孔双燕
机构地区 舟山市人民医院
出处 《浙江实用医学》 2009年第1期51-52,共2页 Zhejiang Practical Medicine
  • 相关文献

参考文献5

二级参考文献31

  • 1曾亮,许叔祥,唐静芬.鳞癌相关抗原在食管鳞癌中的临床检测价值[J].上海医科大学学报,1993,20(2):113-116. 被引量:7
  • 2连利娟 林巧雅.妇科肿瘤学[M].北京:人民卫生出版社,2001.266-277.
  • 3Kato H, Torigoe T. Radioimmunoassay of a rumor antigen of human aquamous cell carcinoma [J]. Cancer, 1977, 40 (3):1621 -1628.
  • 4SuminamiY, Nagashima S, Vujanovic NL, et al. Inhibition of apoptosis in human tumor cell by the tumor-associated serpin,SCC antigen - 1[J]. Br J Cancer, 2000, 82(4):981-989.
  • 5丸尾猛,吉田茂树.子宫頸癌ど腫瘤マ-力-.產婦人科治療[J].1999.79(1):65~70.
  • 6Takeshima N, Hirai Y, Katase K, et al. The value squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer[J]. Gynecol Oncol, 1998, 68 (3):263-266.
  • 7Takeda M, Sakuragi N, Okamoto K, et al. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status insquamous cell carcinoma of the uterine cervix[J]. Acta Obstet Gynecol Scand, 2002, 81(5): 451-455.
  • 8Micke O, Prott FJ, Schafer U, et al. The impact of squuanous cell carcinoma (SCC) antigen in the follow up after radiotherapy inpatients with cervical cancer [J]. Anticancer Res, 2000, 20(6D):5113-5115.
  • 9Barnes RC,Coulter J,Worrall DM.Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2:implications for tumor marker detection[J].Gynecol Oncol,2000,78 (1):62-66.
  • 10Maruo T,Yoshida S,SanotoT,et al.Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix[J].Tumour Biol,1998,19 (6):494-504.

共引文献35

同被引文献40

  • 1刘晓玲,车少敏,王文,姜缨,郑伟.血清SCC与宫颈癌生物学行为的相关性及临床意义[J].西安交通大学学报(医学版),2004,25(6):576-577. 被引量:16
  • 2柯晓慧,胡芝,孙杭临.血清SCCAg在宫颈癌诊疗中的意义[J].临床医学,2006,26(5):65-67. 被引量:7
  • 3赵欣,邵淑丽.鳞状上皮细胞癌抗原与宫颈鳞癌[J].国外医学(妇产科学分册),2007,34(1):60-62. 被引量:17
  • 4高维娇(综述),张蓉(审校).鳞癌相关抗原在宫颈癌中的临床应用价值[J].国际肿瘤学杂志,2007,34(7):532-535. 被引量:3
  • 5Makhlpuf HR,Remotti HE,Ishak KG.Expression of KIT(CD117) in angimydipoma[J].Am J Surg Pathol,2002,26(4):493-497.
  • 6Aoki D,Hirasawa A,Susumu N.Diagnostic significance of turner markers for gynecologic maligancies[J].Japanese Journal of Cancer and Chemotherapy,2005,32(3):411-416.
  • 7Duk BJM,Groenier KH,Bruijn HWA,et al.Pretreatment serum squamous cell carcinoma antigen:a newly identified prognostic factor in early-stage cervical cancer[J].Clin Oncol,1996,14(1):111.
  • 8Homma S, Harada M, Yano H et al. Identification of squa- mous cell carcinoma antigen derived peptides having the capac- ity of inducing cancer reactive CTLs in HLA - A24 + cancer patients [J] . Int J Oncol, 2006, 29 (3): 577.
  • 9Katagiri C, Nakanishi J, Kadoya K et al. Serpin squamous cell carcinoma antigen inhibits UV - induced apoptosis via suppression of c - JUNNH2 - terminal kinase [J]. J Cell Bi- ol, 2006, 172 (7): 983.
  • 10Gadducci A, Tana R, Fanucchi A et al. Biochemical prog- nostic factors and risk of relapses in patients with cervical canc- er [J]. Gyneeol Oncol, 2007, 107 (1 Suppl 1) : $23.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部